State Attorneys General and Pharmaceuticals: Writing a New Prescription to Curtail Drug Costs (December 2007)
by Julie Brill, Vermont Assistant Attorney General and Ano Lobb, M.P.H.
This report is the culmination of the National State Attorneys General Program's efforts to bring together State Attorneys General, academics, and state and federal regulators in an effort to focus on the role that State Attorneys General can play in curtailing current spending on pharmaceuticals by states, consumers, private insurers and employers. At a conference held at Columbia Law School in May 2007, with representation from 38 Attorney General offices, leaders discussed the policy options for states and Attorneys General to pursue in their efforts to implement savings of pharmaceutical dollars. The report summarizes the efforts of states and their Attorneys General in each of these areas, presenting specific solutions currently employed by various states for consideration.
On this page you will find the conference agenda, key background articles, and speaker power point presentations from the conference held at Columbia University on May 10-11, 2007. At the conference leaders discussed the policy options for states and Attorneys General to pursue in their efforts to implement savings of pharmaceutical dollars as well as recent initiatives brought by Attorneys General in their role as the chief law enforcement officers for their states. Panel topics included:
Evidence Based Medicine and Counter-Detailing
State litigation over innovative state laws
Direct to Consumer Advertising and Counter-Advertising
Marketing to Doctors: payments to gain loyalty
Marketing to Doctors: presenting truthful information
Hot Topics in Washington
Formularies and Bulk Purchasing
State and Federal Pharmaceutical Pricing Systems